IBIain Alexander Bruce

Iain Alexander Bruce

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Iain Alexander Bruce has a total of 598 co-authors. Here are the top co-authors by number of shared publications:

  • Lise Henderson

    Richard Ramsden Centre for Auditory Implants, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK

    9 shared publications
  • Stephen J. Broomfield

    Manchester Cochlear Implant Programme, Manchester, UK

    7 shared publications
  • Kevin Green

    6 shared publications
  • M P Rothera

    Department of Paediatric Otolaryngology, Royal Manchester Children's Hospital, Manchester, UK

    6 shared publications
  • Jay Goswamy

    Department of Paediatric Otorhinolaryngology, Royal Manchester Children's Hospital, Oxford Rd., Manchester, Greater Manchester M13 9WL, UK

    5 shared publications
  • Jaya Nichani

    Department of Paediatric Otolaryngology, Royal Manchester Children’s Hospital, Manchester Foundation Trust, Manchester, UK; Division of Human Communication, Development & Hearing, University of Manchester, Faculty of Biology, Medicine & Health, Manchester, UK

    5 shared publications

Latest Publications

  • Open Access

    What Cochlear Implantation with Attempted Hearing Preservation in Widened Vestibular Aqueduct Adds to Understanding About the Etiology and Pathogenesis of Hearing Loss: A Systematic Review

    by Nathan Walker, Hawa Ould-Ahmed, Haroon Saeed, James Dempsey, Matthew Sperrin, Jaya Nichani, Iain A. Bruce

    Widened vestibular aqueduct (WVA) is the commonest congenital inner-ear malformation associated with childhood sensorineural hearing loss. Proposed pathophysiological mechanisms include abnormal endolymph–perilymph pressure regulation, hyperproteinaceous perilymph and impaired ionic homeostasis, particularly in SLC26A4-related disease. These vulnerabilities have raised concerns about the feasibility of hearing preservation cochlear implantation (HPCI).The study aims to evaluate HPCI outcomes in children with WVA and identify prognostic factors that may clarify underlying pathophysiology.A Preferred Reporting Items for Systematic Reviews and Meta-Analyses–compliant systematic review (PROSPERO CRD420251128410) of MEDLINE, Embase, Cochrane Library, and CINAHL from inception to November 2025 identified studies reporting pre- and postoperative unaided thresholds in WVA cochlear implant recipients. Two reviewers independently screened and extracted data. Heterogeneity in outcome definitions required narrative synthesis.Five observational studies including 58 WVA patients (228 total across all cohorts) met inclusion criteria. Hearing preservation ranged from 20%-83% using a variation of outcome criteria. Studies reported improved outcomes with round-window insertion, soft-surgery techniques, and lateral-wall electrodes. In the largest regression analysis, WVA independently predicted poorer preservation. SLC26A4-related WVA did not preclude preservation, and several cohorts reported small postoperative low-frequency threshold changes (

  • Aetiology-specific modification of incision design in OSIA® implantation; a cohort of 46 implants in a tertiary paediatric centre

    by Nathan R. Walker, Jonathan Abbas, Elizabeth Whittle, Azita Rajai, Simone Schaefer, Iain A. Bruce, Jaya Nichani

    Active transcutaneous bone conduction devices have expanded rehabilitation options for children with conductive, mixed, and single-sided deafness (SSD). The Cochlear™ OSIA® system improves hearing while preserving intact skin. We hypothesised that postoperative outcomes vary by operative context and that incision design may influence complication risk. A prospectively maintained database of paediatric patients implanted between September 2021 and April 2026 was retrospectively analysed. Patients were grouped by operative context: (1) microtia/craniofacial anomalies, (2) surgically altered tissues (chronic ear disease/post-mastoidectomy or conversion from percutaneous devices), and (3) normal anatomy (SSD). The primary outcome was soft tissue complications. Secondary outcomes included audiological improvement and subjective benefit (SAC-A). Thirty-four children underwent 46 OSIA® implants (22 unilateral, 12 bilateral); they were aged between 7-19 years and 56% were female. Seventeen had microtia/craniofacial syndromes, twelve had chronic ear disease (including four conversions), and five had SSD. No perioperative complications occurred. Postoperative soft tissue complications occurred in 4/46 implants (8.7%), exclusively in the microtia/craniofacial and surgically altered tissue groups. One explantation was required for late infection; the remainder were managed conservatively or with revision surgery. Significant improvements were seen at 2 kHz (P = 0.009), 4 kHz (P < 0.001), and in speech recognition (86% to 95%, P = 0.004). SAC-A scores improved significantly (36 to 24; P = 0.002), with 94.1% reporting satisfactory usability. Paediatric OSIA® implantation provides substantial audiological benefit with low complication rates. Complications clustered in anatomically or surgically altered tissues, supporting context-specific counselling and surgical planning.

  • Open Access

    Referral and management patterns for paediatric otorrhoea across primary and secondary care: a multicentre retrospective cohort study

    by Elliot Heward, Alexander Collingwood, Farah Jeffry, Shailesh Agrawal, Sharan Jayaram, Darren R. Ashcroft, Alastair D. Hay, Jaya R. Nichani, Iain A. Bruce

    Aim: To determine the frequency and nature of referrals for children with acute or chronic otorrhoea from primary care to secondary care ENT services in the UK. Background: Middle ear infections in children are common; if the ear drum bursts discharge leaks out (otorrhoea). This causes hearing loss during a critical developmental period. Managing these children in an appropriate time frame to prevent disease repercussions is vital. There is currently no evidence demonstrating referral patterns and management strategies across primary and secondary care services. Method: Children with otorrhoea were identified amongst a cohort of 2,100 paediatric ENT (age 0–16 years) referrals from primary care at two secondary care hospital trusts in England in 2023. Chi-squared statistical analysis was performed to compare referral urgency for those with or without hearing loss. Findings: Of the paediatric ENT referrals, 228 (10.9%) had otorrhoea (mean age: 6.4 years, female: n = 110). The most frequent symptom duration at time of referral was >3–6 months (21.1%). Children with hearing loss were not referred more urgently compared to those without reported hearing loss (28.1% vs. 29.4%, p = 0.832). Antibiotic use in primary care was predominantly using oral antibiotics compared to topical antibiotics in secondary care. This study has shown that children with otorrhoea make up a significant proportion of paediatric referrals to the ENT secondary care services in the UK. Current management is heterogenous and could contribute to treatment failure. Standardized management pathways for these patients should be formulated.

  • Open Access

    Protocol for CHIEF (cochlear implants and inner ear inflammation) study; an observational, cross-sectional, study of children and young people undergoing cochlear implantation

    by Kate Hough, Jaya Nichani, Callum Findlay, Iain A Bruce, Tracey A Newman

    Introduction: Cochlear implantation is a surgical treatment that restores hearing function. The implant uses a series of small electrodes to generate electrical currents in the cochlea. These currents simulate the auditory nerve to elicit hearing. Despite the success of this neuro-prosthesis, some people do not get the expected hearing benefit from their implant. One reason for this is that tissues in the cochlea vary in how they respond to the implantation of the electrode array. Many people have a healthy wound healing response that results in a mature scar tissue (fibrosis). However, some people have an altered, or heightened, inflammatory response associated with excessive fibrotic tissue growth in the cochlea. Evidence largely derived from pre-clinical studies shows that excessive tissue ensheathing the electrode array increases the electrical resistance of the current flow (impedance) and reduces the quality of electrical stimulation – both of which can lead to poorer hearing outcomes with the implant. This study will add to our understanding of the people who have a heightened inflammatory response and more vigorous fibrosis (tissue growth) which can lead to poorer hearing outcomes. We propose that there are detectable individual inflammatory differences between people when they are implanted, which may result in variable hearing outcomes following implantation. If we could understand and identify the differences, we could detect people who may be at risk of less favourable outcomes and use targeted treatments, e.g., anti-inflammatories, to improve outcome. Methods and analysis: An observational, cross-sectional, study of children and young people undergoing cochlear implantation. The study will take place at Manchester University Hospital NHS Foundation Trust (MFT) and the University of Southampton. Children and young people who meet the eligibility criteria for cochlear implantation at MFT will be invited to participate in the study. On the day of cochlear implant surgery, a sample of the middle ear mucous membrane, swabs of the nasopharynx and middle ear canal, cochlear fluid, and a blood sample will be collected. Samples will be analysed using a number of molecular techniques to determine the inflammatory status of the person at the time of implantation. Clinical hearing data will be collected for up to five years after implantation to explore the relationship between inflammation at time of implantation and long-term hearing outcomes. Ethics and dissemination: This protocol has been ethically approved by IRAS (330110). Results will be submitted to international peer-reviewed journals and presented at international conferences. Results will be presented to a lay audience via our patient and public involvement and engagement group (ALL_EARS@UoS) website. Article Summary: Strengths and limitations of the study: Strength: The first study that will provide the opportunity to characterise the immune state of the ear at the time of implantation and correlate it with hearing outcomes with a cochlear implant. Strength: The surgical protocol and the participants routine clinical care will not be altered by being a study participant. Strength: The first study to use spatial transcriptomics to characterise the gene expression of human middle ear macrophages in children undergoing cochlear implantation. Limitation: This is an observational study. The results of this study will inform sample size and recruitment criteria for future interventional studies. Limitation: Complete analysis and interpretation of the samples in this study requires several highly specialist and expensive techniques. This will require follow-on funding bids informed using the data from this work.


  • Open Access

    Exploring the burden of paediatric acute otitis media with discharge in the UK: a qualitative study

    by Elliot Heward, Judith Lunn, James Birkenshaw-Dempsey, John Molloy, Rachel Isba, Darren M Ashcroft, Alastair D Hay, Jaya R Nichani, Iain A Bruce

    Background: Acute otitis media with discharge (AOMd) results from a tympanic membrane perforation secondary to a middle ear infection. Currently, the impact of AOMd on children and young people (CYP) and their families is not well understood. There is also a need to explore the experience of healthcare professionals in treating AOMd. Interviews with CYP and their parents, and focus groups with medical professionals, were conducted to explore these objectives.Methods: A total of 26 parents of CYP (age range: 7 months to 15 years) with a history of AOMd (within the last year) and 28 medical professionals were recruited across the UK between August 2023 and March 2024. Healthcare professionals were from primary care (n=17), ear, nose and throat (ENT) (n=7) and emergency medicine (n=4) backgrounds. Thematic analysis was performed independently by three reviewers.Results: The majority of CYP (n=25/26) (96.2%) had suffered from multiple episodes of AOMd. AOMd has a physical, psychological, educational, financial and social impact on CYP and their parents. Parents found accessing healthcare services and information difficult, which increased parental anxiety. Antibiotic overuse was also a concern among parents. The majority of general practitioners and emergency care staff described using oral amoxicillin, compared with ENT doctors who predominantly prescribed topical antibiotics.Conclusions: AOMd has a significant impact on CYP and their parent’s daily lives. Need for clear, easily accessible patient information was identified as a priority by the parents of CYP with AOMd. Evidence-based management guidelines should be developed once high-quality evidence is available.Trial registration number: ISCTRN43760.


  • Open Access

    Enlarged Vestibular Aqueduct and Associated Inner Ear Malformations: Hearing Loss Prognostic Factors and Data Modeling from an International Cohort

    by Haroon S. Saeed, Martin Fergie, Kristianna Mey, Niels West, Per Caye-Thomasen, Robert Nash, Shakeel R. Saeed, Stavros M. Stivaros, Graeme Black, Iain A. Bruce

    BACKGROUND: There is a need to operationalize existing clinical data to support precision medicine in progressive hearing loss (HL). By utilizing enlarged vestibular aqueduct (EVA) and its associated inner ear abnormalities as an exemplar, we model data from a large international cohort, confirm prognostic factors for HL, and explore the potential to generate a prediction model to optimize current management paradigms. METHODS: An international retrospective cohort study. Regression analyses were utilized to model frequency-specific HL and identify prognostic factors for baseline average HL severity and progression. Elastic-net regression and machine learning (ML) techniques were utilized to predict future average HL progression based upon routinely measurable clinical, genetic, and radiological data. RESULTS: Higher frequencies of hearing were lost more severely. Prognostic factors for HL were the presence of incomplete partition type 2 (coefficient 12.95 dB, P=.011, 95% CI 3.0-22 dB) and presence of sac signal heterogeneity (P=.009, 95% CI 0.062-0.429) on magnetic resonance imaging. Elastic-net regression outperformed the ML algorithms (R2 0.32, mean absolute error 11.05 dB) with coefficients for baseline average hearing level and the presence of sac heterogeneity contributing the most to prediction outcomes. CONCLUSION: Incomplete partition type 2 and endolymphatic sac signal heterogeneity phenotypes should be monitored closely for hearing deterioration and need for early audiological rehabilitation/cochlear implant. Preliminary prediction models have been generated using routinely collected health data in EVA. This study showcases how international collaborative research can use exemplar techniques to improve precision medicine in relatively rare disease entities. Cite this article as: Saeed HS, Fergie M, Mey K, et al. Enlarged vestibular aqueduct and associated inner ear malformations: Hearing loss prognostic factors and data modeling from an international cohort. J Int Adv Otol. 2023;19(6):454-460.


  • Open Access

    Mobile audiometry for hearing threshold assessment: A systematic review and meta‐analysis

    by Babatunde Oremule, Jonathan Abbas, Gabrielle Saunders, Karolina Kluk, Rachel Isba, Sebastian Bate, Iain Bruce

    Objectives: Technological advancements in mobile audiometry (MA) have enabled hearing assessment using tablets and smartphones. This systematic review (PROSPERO ID: CRD42021274761) aimed to identify MA options available to health providers, assess their accuracy in measuring hearing thresholds, and explore factors that might influence their accuracy.Design and Setting: A systematic search of online databases including PubMed, Embase, Cochrane, Evidence Search and Dynamed was conducted on 13th December 2021, and repeated on 30th October 2022, using appropriate Medical Subject Headings (MeSH) terms. Eligible studies reported the use of MA to determine hearing thresholds and compared results to conventional pure‐tone audiometry (CA). Studies investigating MA for hearing screening (i.e. reporting just pass/fail) were ineligible for inclusion. Two authors independently reviewed studies, extracted data, and assessed methodological quality and risk of bias using the Quality Assessment of Diagnostic Accuracy Studies‐2 (QUADAS‐2) tool.Participants: Adults and children, with and without diagnosis of hearing impairment.Main outcome measures: A meta‐analysis was performed to obtain the mean difference between thresholds measured using MA and CA in dB HL.Results: Searches returned 858 articles. After systematic review, 17 articles including 1032 participants were analysed. The most used software application was ShoeboxTM (6/17) followed by Hearing TestTM (3/17), then HearTestTM (2/17). Tablet computers were used in ten studies, smartphones in six, and a computer in one. The mean difference between MA and CA thresholds was 1.36 dB (95% CI, 0.07–2.66, p = 0.04). Significant differences between mobile audiometry (MA) and conventional audiometry (CA) thresholds were observed in thresholds measured at 500Hz, in children, when MA was conducted in a sound booth, and when MA was self‐administered. However, these differences did not exceed the clinically significant threshold of 10 decibels (dB). Included studies exhibited high levels of heterogeneity, high risk of bias and low concerns about applicability.Conclusions: MA compares favourably to CA in measuring hearing thresholds and has role in providing access to hearing assessment in situations where CA is not available or feasible. Future studies should prioritize the integration of pure‐tone threshold assessment with additional tests, such as Speech Recognition and Digits‐in‐Noise, for a more rounded evaluation of hearing ability, assesses acceptability and feasibility, and the cost‐effectiveness of MA in non‐specialist settings.


  • Open Access

    Minimally Traumatic Cochlear Implant Surgery: Expert Opinion in 2010 and 2020

    by Vedat Topsakal, Sumit Agrawal, Marcus Atlas, Wolf-Dieter Baumgartner, Kevin Brown, Iain A. Bruce, Stefan Dazert, Rudolf Hagen, Luis Lassaletta, Robert Mlynski, et al.

    This study aimed to discover expert opinion on the surgical techniques and materials most likely to achieve maximum postoperative residual hearing preservation in cochlear implant (CI) surgery and to determine how these opinions have changed since 2010. A previously published questionnaire used in a study published in 2010 was adapted and expanded. The questionnaire was distributed to an international group of experienced CI surgeons. Present results were compared, via descriptive statistics, to those from the 2010 survey. Eighteen surgeons completed the questionnaire. Respondents clearly favored the following: round window insertion, slow array insertion, and the peri- and postoperative use of systematic antibiotics. Insertion depth was regarded as important, and electrode arrays less likely to induce trauma were preferred. The usefulness of dedicated soft-surgery training was also recognized. A lack of agreement was found on whether the middle ear cavity should be flushed with a non-aminoglycoside antibiotic solution or whether a sheath or insertion tube should be used to avoid contaminating the array with blood or bone dust. In conclusion, this paper demonstrates how beliefs about CI soft surgery have changed since 2010 and shows areas of current consensus and disagreement.


  • Open Access

    Mixed Reality Enhanced Otolaryngology Case‐Based Learning: A Randomized Educational Study

    by Rukhnoor Malik, Jonathan R. Abbas, Ceyon Jayarajah, Iain A. Bruce, Neil Tolley

    Introduction: The COVID‐19 pandemic has caused unprecedented disruptions to medical education. Education in medical specialties, such as otolaryngology faces multiple challenges, including reduced bedside and “hands‐on” training opportunities at all levels. Educators are turning to technological advancements to deliver effective remote medical education. This study investigated the value of enhancing traditional remote case‐based teaching with the HoloLens2™.Methods: We present a randomized educational design study. All educational content, media, and learning outcomes were identical. Primary outcome measures included student performance as measured with pre‐ and post‐intervention quizzes and student engagement as measured by a tally‐mark system. Secondary outcome measures, collected using feedback questionnaires, included perceived enjoyment, engagement, and opinions regarding the educational role of this technology.Results: The undergraduate medical students were randomized to either conventional or HoloLens2™ enhanced remote case‐based teaching (n = 56). HoloLens2™ enhanced teaching improved student performance by an average of 3 marks of 15% (p < 0.001). It was engaging and encouraged questions 4‐fold per session (p < 0.05) when compared to conventional remote case‐based teaching. There was no significant difference in overall objective measurements of engagement. Students taught using HoloLens2™ agreed that the teaching was enjoyable, effective in concept demonstration, and encouraged engagement.Conclusions: Remote teaching has allowed for the continuation of medical education in uncertain times. Beyond COVID‐19, we predict that there will be a paradigm shift toward remote learning as new technological advancements emerges. These novel technologies may prove invaluable in the future potentially enabling education to be delivered between different hospitals, universities, and even overseas.Level of Evidence: NA Laryngoscope, 133:1606–1613, 2023


  • Open Access

    The Core Rehabilitation Outcome Set for Single-Sided Deafness (CROSSSD) study: International consensus on outcome measures for trials of interventions for adults with single-sided deafness

    by Roulla Katiri, Deborah A. Hall, Derek J. Hoare, Kathryn Fackrell, Adele Horobin, Nicholas Hogan, Nóra Buggy, Paul H. Van de Heyning, Jill B. Firszt, Iain A. Bruce, et al.

    Background: Single-sided deafness (SSD) has functional, psychological, and social consequences. Interventions for adults with SSD include hearing aids and auditory implants. Benefits and harms (outcome domains) of these interventions are until now reported inconsistently in clinical trials. Inconsistency in reporting outcome measures prevents meaningful comparisons or syntheses of trial results. The Core Rehabilitation Outcome Set for Single-Sided Deafness (CROSSSD) international initiative used structured communication techniques to achieve consensus among healthcare users and professionals working in the field of SSD. The novel contribution is a set of core outcome domains that experts agree are critically important to assess in all clinical trials of SSD interventions. Methods: A long list of candidate outcome domains compiled from a systematic review and published qualitative data, informed the content of a two-round online Delphi survey. Overall, 308 participants from 29 countries were enrolled. Of those, 233 participants completed both rounds of the survey and scored each outcome domain on a 9-point scale. The set of core outcome domains was finalised via a web-based consensus meeting with 12 participants. Votes involved all stakeholder groups, with an approximate 2:1 ratio of professionals to healthcare users participating in the Delphi survey, and a 1:1 ratio participating in the consensus meeting. Results: The first round of the survey listed 44 potential outcome domains, organised thematically. A further five outcome domains were included in Round 2 based on participant feedback. The structured voting at round 2 identified 17 candidate outcome domains which were voted on at the consensus meeting. Consensus was reached for a core outcome domain set including three outcome domains: spatial orientation, group conversations in noisy social situations, and impact on social situations. Seventy-seven percent of the remaining Delphi participants agreed with this core outcome domain set. Conclusions: Adoption of the internationally agreed core outcome domain set would promote consistent assessment and reporting of outcomes that are meaningful and important to all relevant stakeholders. This consistency will in turn enable comparison of outcomes reported across clinical trials comparing SSD interventions in adults and reduce research waste. Further research will determine how those outcome domains should best be measured.